Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A southwest oncology group study

Lung Cancer ◽  
1987 ◽  
Vol 3 (1) ◽  
pp. 51
Keyword(s):  
Combination Chemotherapy ◽  
Large Cell ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Adenocarcinoma Of The Lung ◽  
Ambulatory Patients ◽  
Southwest Oncology Group Study

Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study.

1985 ◽  
Vol 3 (10) ◽  
pp. 1318-1324 ◽  
Author(s):  
S E Jones ◽  
P N Grozea ◽  
T P Miller ◽  
E J Van Slyck ◽  
S P Balcerzak ◽  
...  
Keyword(s):  
Malignant Lymphoma ◽  
Cell Lymphoma ◽  
Large Cell ◽  
Oncology Group ◽  
Chop Chemotherapy ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study ◽  
Large Cell Lymphoma ◽  
Histologic Types

Between 1977 and 1983 the Southwest Oncology Group (SWOG) evaluated chemotherapy alone (cyclophosphamide, doxorubicin, vincristine, prednisone; CHOP) or chemoimmunotherapy (CHOP-levamisole or CHOP-levamisole-BCG) in a randomized prospective clinical trial involving 715 eligible patients with all types of malignant lymphoma (ML). Of 281 evaluable patients with favorable histologic types of ML, 171 (61%) achieved complete remission (CR) and there was no difference in CR rate, CR duration, or survival according to the type of initial treatment. Of 388 evaluable patients with unfavorable histologic types of ML, 194 (50%) achieved CR. Levamisole appeared to adversely affect CR rates in nodular mixed and nodular large-cell lymphoma and CR duration in patients with unfavorable histology ML. Chemoimmunotherapy with levamisole or levamisole-BCG offers no advantage in terms of CR rates, CR duration, or survival compared to CHOP chemotherapy alone, and levamisole may have had an adverse impact on outcome in certain subtypes of ML.

Alternating Combination Chemotherapy and Levamisole Improves Survival in Multiple Myeloma

1983 ◽  
Vol 1 (10) ◽  
pp. 667-667 ◽  
Author(s):  
Sydney E. Salmon ◽  
Arthur Haut ◽  
John D. Bonnet ◽  
Mammo Amare ◽  
James K. Weick ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Combination Chemotherapy ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study

In the August issue of the Journal, the article by Salmon et al (1:453–461, 1983) contained an error. At the request of the authors, the title of the article should not have included mention of Levamisole, but rather should have read "Alternating Combination Chemotherapy Improves Survival in Multiple Myeloma: A Southwest Oncology Group Study,"

Doxorubicin-cisplatin-vinblastine combination chemotherapy of advanced endometrial carcinoma: A Southwest Oncology Group study

1987 ◽  
Vol 26 (2) ◽  
pp. 193-201 ◽  
Author(s):  
David S. Alberts ◽  
Nancy L. Mason ◽  
Robert V. O'Toole ◽  
Robert D. Hilgers ◽  
Saul E. Rivkin ◽  
...  
Keyword(s):  
Endometrial Carcinoma ◽  
Combination Chemotherapy ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study

Evaluation of cis-Platinum and DTIC Combination Chemotherapy in Disseminated Melanoma A Southwest Oncology Group Study

1988 ◽  
Vol 11 (5) ◽  
pp. 589-593 ◽  
Author(s):  
William S. Fletcher ◽  
Stephanie Green ◽  
John R. Fletcher ◽  
Bruce Dana ◽  
William Jewell ◽  
...  
Keyword(s):  
Combination Chemotherapy ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study

Combination chemotherapy plus BCG in the treatment of disseminated malignant melanoma: A southwest oncology group study

1982 ◽  
Vol 10 (3) ◽  
pp. 251-258 ◽  
Author(s):  
John J. Costanzi ◽  
Muhyi Al-Sarraf ◽  
Carl Groppe ◽  
Richard Bottomley ◽  
Carol Fabian ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Combination Chemotherapy ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study
Sign in / Sign up

Export Citation Format

Share Document